Author

J. Morales-Valencia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

G. David· 2 shared A. Calderon· 1 shared L. Lau· 1 shared S. Saini· 1 shared T. Marti-Nin· 1 shared U. Ozerdem· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

G. David

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The chromatin associated Sin3B is a critical regulator of DNA damage repair through the engagement of the Non-Homologous End Joining.

J. Morales-Valencia, A. Calderon, S. Saini, G. David

This study shows Sin3B is critical for DNA damage repair by promoting non-homologous end joining through MDC1 recruitment, highlighting its role in genomic integrity and potential as a cancer therapeutic target.

bioRxiv · Mar 9, 2022 · PreprintCancer Biology

Lipocalin 2 upregulation mediates the detrimental effects of therapy-induced senescence in breast cancer cells.

J. Morales-Valencia, L. Lau, T. Marti-Nin, U. Ozerdem, G. David

This study shows that Lipocalin 2 upregulation in breast cancer cells driven by therapy-induced senescence promotes migration and reduces chemotherapy effectiveness, correlating with poor patient survival.

bioRxiv · Mar 8, 2022 · PreprintCancer Biology